NVIDIA Halts RTX 50 Series Production to Focus on AI Demand
Recent reports indicate that NVIDIA is shifting its focus away from the RTX 50 series production to meet rising demand for AI GPUs. A leak from Moore’s Law Is Dead suggests that GDDR7 memory, initially intended for upcoming graphics cards, will be repurposed for NVIDIA’s AI projects.
NVIDIA’s RTX 50 Series Production Halt
According to sources, the production of specific models such as the RTX 5070 Ti and RTX 5060 Ti 16GB has already ended. The RTX 5070 Ti is currently scarce, leading its prices to soar. This shift prioritizes AI products amidst a reported overbooking of AI GPU sales.
Current GPU Market Dynamics
The supply of RTX 50 series graphics cards is expected to dwindle. NVIDIA reportedly lacks sufficient memory resources for consumer versions, as most of these resources are being redirected towards AI GPUs. A supply chain source noted:
- The RTX 5060 is projected to remain out of production for the next six months.
- High VRAM models like the RTX 5090 and 5070 Ti will also see limited availability.
- Only the special case of RTX 5060 Ti 8GB will continue production, albeit at a low volume.
Users were previously aware of production challenges affecting the RTX 5070 Ti and 5060 Ti 16GB, but the end of RTX 5060 production came as a surprise.
Consumer Choices and Supply Outlook
NVIDIA’s RTX 60-class cards, particularly the RTX 3060 and 4060, maintain popularity among gamers. This situation leaves consumers with the following options:
- RTX 5080
- RTX 5070
- RTX 5060 Ti 8GB
However, these models are also expected to be in short supply. Retail sources have hinted that supply issues for the RTX 5060 may worsen until at least Q4. In the meantime, the RTX 5050, utilizing GDDR6 memory, will remain in production as it does not compete for the GDDR7 resources.
Conclusion
NVIDIA’s decision to halt RTX 50 series production highlights a significant shift towards AI technology. This reallocation also reflects broader trends in the GPU market, where consumer product availability may continue to face challenges.
